BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nicoli F, Appay V. Immunological considerations regarding parental concerns on pediatric immunizations. Vaccine 2017;35:3012-9. [PMID: 28465096 DOI: 10.1016/j.vaccine.2017.04.030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Barman S, Soni D, Brook B, Nanishi E, Dowling DJ. Precision Vaccine Development: Cues From Natural Immunity. Front Immunol 2021;12:662218. [PMID: 35222350 DOI: 10.3389/fimmu.2021.662218] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
2 Nicoli F, Pacifico S, Gallerani E, Marzola E, Albanese V, Finessi V, Llewellyn-Lacey S, Price DA, Appay V, Marconi P, Guerrini R, Caputo A, Gavioli R. Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines. Vaccines (Basel) 2021;9:526. [PMID: 34069535 DOI: 10.3390/vaccines9050526] [Reference Citation Analysis]
3 Lepiller Q, Bouiller K, Slekovec C, Millot D, Mazué N, Pourchet V, Balice R, Garrien-Maire F, Simon E, Wintenberger V, Guillaume A, Monaton MF, Van Eis B, Bertrand X, Bennabi D, Moulin T, Anxionnat R, Nerich V. Perceptions of French healthcare students of vaccines and the impact of conducting an intervention in health promotion. Vaccine 2020;38:6794-9. [PMID: 32896467 DOI: 10.1016/j.vaccine.2020.08.036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
4 Papagno L, Kuse N, Lissina A, Gostick E, Price DA, Appay V, Nicoli F. The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8+ T-cell responses in vitro. Sci Rep 2020;10:11620. [PMID: 32669577 DOI: 10.1038/s41598-020-67704-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Nicoli F, Gallerani E, Sicurella M, Pacifico S, Cafaro A, Ensoli B, Marconi P, Caputo A, Gavioli R. The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation. Vaccines (Basel) 2020;8:E274. [PMID: 32512757 DOI: 10.3390/vaccines8020274] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Dolhain J, Janssens W, Dindore V, Mihalyi A. Infant vaccine co-administration: review of 18 years of experience with GSK's hexavalent vaccine co-administered with routine childhood vaccines. Expert Rev Vaccines 2020;19:419-43. [PMID: 32419537 DOI: 10.1080/14760584.2020.1758560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Gilmartin CE, Daley AJ, Leung L. The hepatitis B birth-dose immunisation: Exploring parental refusal. Aust N Z J Obstet Gynaecol 2020;60:93-100. [PMID: 31259386 DOI: 10.1111/ajo.13008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
8 Bean SJ, Catania JA. Immunology beliefs as a factor in vaccine opposition among complementary and alternative medical providers. SAGE Open Med 2018;6:2050312118807625. [PMID: 30455945 DOI: 10.1177/2050312118807625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Butkeviciute E, Jones CE, Smith SG. Heterologous effects of infant BCG vaccination: potential mechanisms of immunity. Future Microbiol 2018;13:1193-208. [PMID: 30117744 DOI: 10.2217/fmb-2018-0026] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 12.0] [Reference Citation Analysis]